Microfluidics-Based Organism Isolation from Whole Blood: An Emerging Tool for Bloodstream Infection Diagnosis

Area of Science:

• Biomedical Engineering
• Clinical Diagnostics
• Microfluidics

Background:

• Bloodstream infections (BSI) pose diagnostic challenges due to low pathogen concentrations.
• Traditional culture-based methods for BSI diagnosis are time-consuming.
• Rapid and accurate pathogen identification is critical for effective sepsis treatment.

Purpose of the Study:

• To review and compare emerging microfluidic platforms for pathogen isolation from blood.
• To highlight the advantages of microfluidics over conventional diagnostic techniques.
• To identify future research directions in microfluidic-based BSI diagnostics.

Main Methods:

• Review of current literature on microfluidic devices for pathogen enrichment and detection.
• Comparative analysis of different microfluidic platform designs and their performance metrics.
• Focus on platforms for isolating bacterial and fungal pathogens from blood.

Main Results:

• Microfluidic devices demonstrate potential for rapid, high-throughput pathogen isolation.
• These platforms enable integrated bacterial and fungal enrichment, detection, and characterization.
• Emerging technologies offer significant improvements over traditional culture-based diagnostics.

Conclusions:

• Microfluidic platforms represent a promising advancement in the rapid diagnosis of bloodstream infections.
• Further research is needed to optimize these devices for clinical application.
• The development of advanced microfluidic tools can significantly impact sepsis patient outcomes.